Brief: Revvity, Element Biosciences Collaborate To Advance Sequencing-Based Ivd Neonatal Testing
13/01/2025 14:28
Jan 13 (Reuters) - Revvity Inc RVTY.N :
* REVVITY: CO, ELEMENT BIOSCIENCES COLLABORATE TO ADVANCE
SEQUENCING-BASED IVD NEONATAL TESTING
Source text: ID:nBw8MWsZha
Further company coverage: RVTY.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Revvity
See all newsBrief: Revvity Launches Signals Labgistics Solution To Connect And Orchestrate Scientific Workflows
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT